Somatic delivery of catecholamines in the striatum attenuate parkinsonian symptoms and widen the therapeutic window of oral sinemet in rats

Experimental Neurology
M D LindnerD F Emerich

Abstract

Guidelines for clinical transplantation studies for Parkinson's disease emphasize that transplants should be considered as an adjunct to systemic L-DOPA, yet few preclinical studies have specifically assessed the potential of transplants as an adjunct to the clinical gold standard treatment. The objectives of the present study were to determine if encapsulated PC12 cells implanted in rats with severe unilateral dopamine depletions: (i) have a direct therapeutic effect on measures of parkinsonian symptoms; and/or (ii) increase the therapeutic window of oral sinemet in this model. Rats with severe unilateral dopamine depletions received striatal implants of encapsulated PC12 cells producing dopamine and L-DOPA. These rats were tested on a battery of behavioral measures of parkinsonian symptoms, at a range of doses of oral sinemet (0, 12, 24, and 36 mg/kg). Stereotypies/dyskinesias were also quantified after high doses of oral sinemet (36 and 50 mg/kg). The results confirm that parkinsonian symptoms can be quantified in rats with severe dopamine depletions, and the validity and clinical relevance of these measures are supported by the fact that the clinical gold standard treatment, oral sinemet, attenuates these parkinsonian sympt...Continue Reading

References

Nov 1, 1976·Journal of Clinical Pharmacology·P Delaney, J Fermaglich
Jul 1, 1976·Proceedings of the National Academy of Sciences of the United States of America·L A Greene, A S Tischler
Jan 1, 1992·Movement Disorders : Official Journal of the Movement Disorder Society·J W LangstonR Watts
Nov 1, 1990·Experimental Neurology·K Steece-CollierJ R Sladek
Jan 1, 1986·Experimental Brain Research·W J FreedH M Geller
Jan 1, 1981·Journal of Neural Transmission·U K RinneV Koskinen
Oct 1, 1980·Journal of Comparative and Physiological Psychology·J F MarshallS Sawyer
Nov 1, 1993·Trends in Neurosciences·C W Olanow
Jan 1, 1995·Annual Review of Neuroscience·F H GageL J Fisher
Jan 1, 1994·Neurobiology of Aging·F H Gage
Sep 1, 1994·Progress in Neuro-psychopharmacology & Biological Psychiatry·D F EmerichS R Winn
Jul 1, 1993·Experimental Neurology·D F EmerichS R Winn
Jan 1, 1995·Fundamental & Clinical Pharmacology·P J BlanchetP J Bédard
Feb 1, 1996·Brain : a Journal of Neurology·G L DeferJ P Nguyen
Jan 1, 1996·European Neurology·F StocchiS Ruggieri
Sep 1, 1996·Trends in Neurosciences·S WeissD van der Kooy

❮ Previous
Next ❯

Citations

Jul 8, 2009·Regenerative Medicine·Dwaine F Emerich, Alfred Vasconcellos
Oct 12, 2010·Journal of Angiogenesis Research·Ariel Gilert, Marcelle Machluf
Aug 6, 2009·Nature Reviews. Neuroscience·Gorka OriveDwaine F Emerich
Sep 9, 1999·Cell Transplantation·H YoshidaT Ohmoto
Aug 16, 2000·Advanced Drug Delivery Reviews·P A TrescoM D Noble

❮ Previous
Next ❯

Related Concepts

Related Feeds

Basal Ganglia

Basal Ganglia are a group of subcortical nuclei in the brain associated with control of voluntary motor movements, procedural and habit learning, emotion, and cognition. Here is the latest research.